Problems viewing this email?

Go to the ESGVH Newsletter page to see the information online.

July 2013

Dear Colleague,
Here is another newsletter from ESGVH reporting on several important issues that have happened during the past few months. There is an update on the recent ECCMID 2013 conference in Berlin, followed by a summary of the business meeting introducing the new executive committee of ESGVH, and providing news regarding research and teaching initiatives taken by our study group. We hope you will find this of interest. For further information about our study group and for getting involved and for becoming a member please visit the ESGVH website

Viral Hepatitis @ ECCMID 2013 in Berlin, DE

At the 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2013 in Berlin, a number of well-attended sessions dealt with viral hepatitis. The ESGVH website lists them and the direct link to materials from these sessions available in the ESCMID Online Lecture Library ( In all, at this ECCMID conference in Berlin there were many very interesting sessions on viral hepatitis with excellent speakers and many attendees. This is encouraging for coming ECCMID conferences.


ESGVH Business Meeting 2013 - change of executive committee

The new ESGVH executive committee consists of Joop Arends (Chair), Dominique Salmon (Secretary) and Badreddine Kilani (Treasurer).

We wish to thank the previous committee consisting of Dominique Salmon (Chair), Andy Hoepelman (Secretary) and Will Irving (Treasurer) for the outstanding work and enthusiasm for the study group.

Postgraduate Education Course

From 28 February to 1 March 2014 a postgraduate education course will be held in Istanbul entitled “Viral Hepatitis: Recent advances in diagnosis and treatment”. This course, organised by Prof Hakan Leblebicioglu,  is supported by ESCMID and all details can be found on the course website.

Research projects

Members of ESGVH have proposed two projects:

  1. Collect data on persistent low level HBV-DNA detectability in HIV/ HBV coinfected patients treated with tenofovir (TDF); led by Katrine Lacombe from Paris;
  2. Setting up a biobank on confirmed hepatitis E cases; led by Will Irving from Nottingham.

It was decided to support both projects and apply for Study Group Research Grants to receive ESCMID funding for them.

Proposals for ECCMID 2014

The ESCMID programme committee has notified the study groups recently that 2 of our proposals have been granted. They are:

  • 2‐hour Educational Workshop entitled “Viral infections in pregnancy”. The topics to be discussed are 1) Hepatitis B in pregnancy (Resat Ozaras), 2) Hepatitis C in pregnancy (Marie-Louise Newell) 3) Prevention of mother to child transmission of HIV (François Dabis) and Hepatitis E in pregnancy (Udayakumar Navaneethan);
  • Meet‐the‐Expert Session entitled “The management of HIV/HCV infection in the era of direct active drugs”. Speakers will be Dominique Salmon and David Back.

The ECCMID 2014 preliminary programme will soon be published. Check the congress website for latest updates.

Scientific publications

ESGVH is working on several publications for 2013, check out the ESGVH website for more details and for getting involved.

Become an ESGVH Member now!

We are very keen on keeping in touch with and getting to know all who are interested in viral hepatitis. If you are interested to become more involved in our study group, please become an ESGVH member (ESGVH membership link). This will take only a few minutes.

Thank you for your interest in ESGVH. We hope to see you in Barcelona next year.

Warm regards,

The e-mail is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.
You can unsubscribe by answering this email and including the word 'unsubscribe' in the subject line.